Real-time enrollment status for this cll / sll clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 1:02 AM UTC
| NCT Number | NCT07342478 |
| Recruiting Status | Recruiting |
| Condition | CLL / SLL |
| Phase | PHASE3 |
| Target Enrollment | 306 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Newave Pharmaceutical Inc |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 17, 2026: Clinical trial NCT07342478 is currently recruiting participants. This phase3 study for cll / sll is actively seeking new participants at 4 locations across the United States. The study is sponsored by Newave Pharmaceutical Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07342478 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07342478 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.